Atezolizumab and Bevacizumab for Treatment of Patients With Unresectable / Non-transplantable Advanced Hepatocellular Carcinoma: A Real-World Single Center Experience from North India.

Dhampalwar, Swapnil; Choudhary, Narendra S; Saraf, Neeraj; Bhangui, Prashant; Soin, Arvinder S

Dhampalwar, Swapnil; Choudhary, Narendra S; Saraf, Neeraj; Bhangui, Prashant; Soin, Arvinder S.

Afiliación

Dhampalwar S; Institute of Liver Transplantation & Regenerative Medicine, Medanta- The Medicity, Gurugram, India.
Choudhary NS; Institute of Liver Transplantation & Regenerative Medicine, Medanta- The Medicity, Gurugram, India.
Saraf N; Institute of Liver Transplantation & Regenerative Medicine, Medanta- The Medicity, Gurugram, India.
Bhangui P; Institute of Liver Transplantation & Regenerative Medicine, Medanta- The Medicity, Gurugram, India.
Soin AS; Institute of Liver Transplantation & Regenerative Medicine, Medanta- The Medicity, Gurugram, India.

J Clin Exp Hepatol ; 14(1): 101219, 2024.

Article en En | MEDLINE | ID: mdl-38076355

Palabras clave

Atezolizumab; Bevacizumab; advanced HCC; immunotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Clin Exp Hepatol Año: 2024 Tipo del documento: Article País de afiliación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google